Q1 Earnings Forecast for SBC Medical Group Issued By Sidoti

SBC Medical Group Holdings Incorporated (NASDAQ:SBC) – Sidoti dropped their Q1 2026 EPS estimates for shares of SBC Medical Group in a report released on Wednesday, April 1st. Sidoti analyst A. Shah now forecasts that the company will post earnings per share of $0.10 for the quarter, down from their previous forecast of $0.11. The consensus estimate for SBC Medical Group’s current full-year earnings is $5.02 per share. Sidoti also issued estimates for SBC Medical Group’s Q2 2026 earnings at $0.12 EPS, Q3 2026 earnings at $0.12 EPS, Q4 2026 earnings at $0.13 EPS, FY2026 earnings at $0.47 EPS, Q1 2027 earnings at $0.12 EPS, Q2 2027 earnings at $0.13 EPS, Q3 2027 earnings at $0.13 EPS, Q4 2027 earnings at $0.13 EPS and FY2027 earnings at $0.52 EPS.

Several other equities analysts have also recently issued reports on the company. BTIG Research started coverage on SBC Medical Group in a research note on Friday, March 6th. They issued a “buy” rating and a $8.00 price objective for the company. Weiss Ratings restated a “sell (d+)” rating on shares of SBC Medical Group in a research note on Friday, March 27th. Two research analysts have rated the stock with a Buy rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average price target of $8.50.

SBC Medical Group Stock Performance

SBC opened at $4.47 on Thursday. The business has a fifty day moving average price of $4.12 and a 200 day moving average price of $4.04. The company has a debt-to-equity ratio of 0.13, a current ratio of 3.78 and a quick ratio of 5.06. SBC Medical Group has a 12 month low of $2.97 and a 12 month high of $5.75. The stock has a market capitalization of $458.53 million, a price-to-earnings ratio of 9.12 and a beta of 0.99.

SBC Medical Group (NASDAQ:SBC) last announced its quarterly earnings data on Friday, March 27th. The company reported $0.14 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.13 by $0.01. The business had revenue of $39.57 million for the quarter, compared to analysts’ expectations of $45.19 million. SBC Medical Group had a return on equity of 20.76% and a net margin of 29.37%.

Institutional Trading of SBC Medical Group

Several institutional investors have recently modified their holdings of the stock. Geode Capital Management LLC acquired a new position in shares of SBC Medical Group in the 2nd quarter valued at $455,000. XTX Topco Ltd acquired a new stake in SBC Medical Group during the 2nd quarter worth $64,000. New York State Common Retirement Fund acquired a new stake in SBC Medical Group during the 2nd quarter worth $104,000. Millennium Management LLC purchased a new stake in SBC Medical Group in the third quarter valued at $219,000. Finally, Williams & Novak LLC acquired a new position in SBC Medical Group in the fourth quarter valued at $65,000. Hedge funds and other institutional investors own 60.82% of the company’s stock.

Insiders Place Their Bets

In related news, CEO Yoshiyuki Aikawa sold 4,422,900 shares of the business’s stock in a transaction that occurred on Friday, March 6th. The stock was sold at an average price of $2.12, for a total transaction of $9,376,548.00. Following the completion of the sale, the chief executive officer owned 861,600 shares in the company, valued at $1,826,592. The trade was a 83.70% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 89.47% of the stock is currently owned by insiders.

Key Stories Impacting SBC Medical Group

Here are the key news stories impacting SBC Medical Group this week:

• Positive Sentiment: Q4 2025 earnings/call — SBC reported an EPS beat and management outlined strategic expansion and margin initiatives that could support future revenue and profitability. That execution narrative helps explain buying interest despite revenue coming in below some expectations. Earnings Call Highlights
• Neutral Sentiment: Analyst commentary piece — a broader analysts’ roundup mentioned SBC alongside peers, offering additional context but no major fresh rating changes; useful for background but unlikely to move the stock alone. Analysts Offer Insights
• Negative Sentiment: Multiple Sidoti estimate cuts — Sidoti lowered near‑term quarterly EPS forecasts (Q1–Q4 2026, several 2027 quarters) and trimmed FY2026 and FY2027 earnings projections (FY2026 to $0.47, FY2027 to $0.52 from prior higher marks). These repeated downgrades increase downside risk to sentiment and could pressure the stock if other analysts follow or if guidance revisions continue.

About SBC Medical Group

SBC Medical Group, Inc is a publicly traded healthcare management services company listed on the Nasdaq under the ticker SBC. The company specializes in supporting in-office ancillary service providers by offering a suite of administrative and operational solutions designed to streamline practice management and enhance revenue performance. Its core mission is to help physician practices, imaging centers and other ancillary service providers focus on patient care while outsourcing complex back-office functions.

The company’s primary offerings include revenue cycle management, medical billing and coding, compliance oversight and transcription services.